PF-06439535 (a Bevacizumab Biosimilar) Compared with Reference Bevacizumab (Avastin®), Both Plus Paclitaxel and Carboplatin, as First-Line Treatment for Advanced Non-Squamous Non-Small-Cell Lung Cancer: A Randomized, Double-Blind Study
2019 ◽
Vol 33
(5)
◽
pp. 555-570
◽
Niels Reinmuth
◽
Maciej Bryl
◽
Igor Bondarenko
◽
Kostas Syrigos
◽
Vladimir Vladimirov
◽
...
Caicun Zhou
◽
Lin Wu
◽
Yun Fan
◽
Zhehai Wang
◽
Lianke Liu
◽
...
Y. Belaroussi
◽
S. Cousin
◽
M. Carton
◽
M. Lebitasy
◽
L. Laborde
◽
...
2020 ◽
Vol 9
(10)
◽
pp. 3328-3336
◽
Haiyan Xu
◽
Quan Zhang
◽
Li Liang
◽
Junling Li
◽
Zhefeng Liu
◽
...
2019 ◽
Vol 8
(8)
◽
pp. E11-E14
Teppei Yamaguchi
◽
Toyoaki Hida
2009 ◽
Vol 9
(4)
◽
pp. 425-435
◽
Marcello Tiseo
◽
Marco Bartolotti
◽
Francesco Gelsomino
◽
Andrea Ardizzoni
2010 ◽
Vol 67
(2)
◽
pp. 475-479
◽
Xin-Hua Xu
◽
Jin Su
◽
Xiang-Yang Fu
◽
Feng Xue
◽
Qiao Huang
◽
...
2003 ◽
Vol 39
(1)
◽
pp. 77-84
◽
J.M Vieitez
◽
M Valladares
◽
M Gracia
◽
M Gonzalez-Barón
◽
G Martı́n
◽
...
Nan Qiao
◽
Ralph Insinga
◽
Thomas Burke
◽
Gilberto Lopes
2018 ◽
Vol 29
◽
pp. x40-x41
◽
N.A. Rizvi
◽
B. Chul Cho
◽
N. Reinmuth
◽
K.H. Lee
◽
M.-J. Ahn
◽
...
Close
Export Citation Format
Close
Share Document
Close